Follow
S. Duygu Selcuklu
S. Duygu Selcuklu
Verified email at mskcc.org
Title
Cited by
Cited by
Year
HER kinase inhibition in patients with HER2-and HER3-mutant cancers
DM Hyman, SA Piha-Paul, H Won, J Rodon, C Saura, GI Shapiro, D Juric, ...
Nature 554 (7691), 189-194, 2018
6662018
miR-21 as a key regulator of oncogenic processes
SD Selcuklu, MTA Donoghue, C Spillane
Biochemical Society Transactions 37 (4), 918-925, 2009
5892009
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
AM Miller, RH Shah, EI Pentsova, M Pourmaleki, S Briggs, N Distefano, ...
Nature 565 (7741), 654-658, 2019
4432019
Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid
EI Pentsova, RH Shah, J Tang, A Boire, D You, S Briggs, A Omuro, X Lin, ...
Journal of clinical oncology 34 (20), 2404, 2016
3532016
Tumour lineage shapes BRCA-mediated phenotypes
P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, ...
Nature 571 (7766), 576-579, 2019
3332019
AKT inhibition in solid tumors with AKT1 mutations
DM Hyman, LM Smyth, MTA Donoghue, SN Westin, PL Bedard, EJ Dean, ...
Journal of Clinical Oncology 35 (20), 2251, 2017
2812017
MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells
SD Selcuklu, MTA Donoghue, K Rehmet, M de Souza Gomes, A Fort, ...
Journal of Biological Chemistry 287 (35), 29516-29528, 2012
2292012
Genomic biomarkers of a randomized trial comparing first-line everolimus and sunitinib in patients with metastatic renal cell carcinoma
JJ Hsieh, D Chen, PI Wang, M Marker, A Redzematovic, YB Chen, ...
European urology 71 (3), 405-414, 2017
2082017
Resistance to TRK inhibition mediated by convergent MAPK pathway activation
E Cocco, AM Schram, A Kulick, S Misale, HH Won, R Yaeger, P Razavi, ...
Nature medicine 25 (9), 1422-1427, 2019
1742019
Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition
JJ Harding, MA Lowery, AH Shih, JM Schvartzman, S Hou, C Famulare, ...
Cancer discovery 8 (12), 1540-1547, 2018
1562018
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer
LM Smyth, SA Piha-Paul, HH Won, AM Schram, C Saura, S Loi, J Lu, ...
Cancer discovery 10 (2), 198-213, 2020
1072020
Phase II trial and correlative genomic analysis of everolimus plus bevacizumab in advanced non–clear cell renal cell carcinoma
MH Voss, AM Molina, YB Chen, KM Woo, JL Chaim, DT Coskey, ...
Journal of Clinical Oncology 34 (32), 3846, 2016
772016
Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM-and PUMA-mediated apoptosis
K Tanaka, AY Helena, S Yang, S Han, SD Selcuklu, K Kim, S Ramani, ...
Cancer Cell 39 (9), 1245-1261. e6, 2021
632021
An NTD‐Associated Polymorphism in the 3′ UTR of MTHFD 1 L can Affect Disease Risk by Altering mi RNA Binding
S Minguzzi, SD Selcuklu, C Spillane, A Parle‐McDermott
Human Mutation 35 (1), 96-104, 2014
492014
An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions
SD Selcuklu, MC Yakicier, AE Erson
Cancer genetics and cytogenetics 189 (1), 15-23, 2009
492009
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway
MM Rubinstein, DM Hyman, I Caird, H Won, K Soldan, K Seier, A Iasonos, ...
Cancer 126 (6), 1274-1282, 2020
372020
Regulatory interplay between miR-21, JAG1 and 17beta-estradiol (E2) in breast cancer cells
SD Selcuklu, MTA Donoghue, MJ Kerin, C Spillane
Biochemical and biophysical research communications 423 (2), 234-239, 2012
342012
Noninvasive detection of polyclonal acquired resistance to FGFR inhibition in patients with cholangiocarcinoma harboring FGFR2 alterations
AM Varghese, J Patel, YY Janjigian, F Meng, SD Selcuklu, G Iyer, ...
JCO Precision Oncology 5, 44-50, 2021
302021
Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
DWY Tsui, ML Cheng, M Shady, JL Yang, D Stephens, H Won, ...
Genome medicine 13 (1), 96, 2021
282021
Germ cell tumor molecular heterogeneity revealed through analysis of primary and metastasis pairs
ML Cheng, MTA Donoghue, F Audenet, NC Wong, EJ Pietzak, CM Bielski, ...
JCO Precision Oncology 4, 1307-1320, 2020
152020
The system can't perform the operation now. Try again later.
Articles 1–20